NEURO-ONCOLOGY Journal

publication venue for

Integrating single-cell and spatial transcriptomics reveals endoplasmic reticulum stress-related CAF subpopulations associated with chordoma progression 2023
New targets in the glioblastoma tumor microtube multiverse: Emerging roles for the TGF-beta/TSP1 signaling axis 2022
A MULTI-INSTITUTIONAL RANDOMIZED CLINICAL TRIAL COMPARING ASSAY - GUIDED CHEMOTHERAPY WITH PHYSICIAN-CHOICE TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA (NCT03632135) 2022
INITIAL ANALYSIS OF PHASE-III TRIAL - STANDARD CHEMOTHERAPY VS. CHEMOTHERAPY GUIDED BY A CANCER STEM CELL TEST IN RECURRENT GLIOBLASTOMA (NCT03632135) 2020
PHASE-III TRIAL OF STANDARD CHEMOTHERAPY VS. CHEMOTHERAPY GUIDED BY CANCER STEM CELL TEST IN RECURRENT GLIOBLASTOMA (NCT03632135) 2019
TARGETING THE FORMIN-DIRECTED CYTOSKELETON WITH SMALL MOLECULE AGONISTS BLOCKS GLIOBLASTOMA PATIENT-DERIVED NEUROSPHERE INVASION 2018
EVALUATION OF RISK FACTORS FOR DEATH WITHIN THREE MONTHS AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES 2014
EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) 2014
A PILOT PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (hypo-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) 2013

category

CLINICAL NEUROLOGY Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

1522-8517

Electronic International Standard Serial Number (EISSN)

1523-5866

journal abbreviation

NEURO-ONCOLOGY